AstraZeneca
AZN
331 hedge funds and large institutions have $5.84B invested in AstraZeneca in 2013 Q2 according to their latest regulatory filings, with 331 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
227% more call options, than puts
Call options by funds: $100M | Put options by funds: $30.6M
9.87% more ownership
Funds ownership: 0% → 9.87% (+9.9%)
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KTC
326
Kistler-Tiffany Companies
Berwyn,
Pennsylvania
| $7K | +$7.74K | +152 | New |
|
|
BC
327
Bartlett & Co
Cincinnati,
Ohio
| $4K | +$3.82K | +75 | New |
|
|
RFA
328
Reilly Financial Advisors
La Mesa,
California
| $3K | +$2.75K | +54 | New |
|
|
LM
329
Lincluden Management
Mississauga,
Ontario, Canada
| $2.03K | +$2.19M | +43,020 | New |
|
|
HR
330
Howe & Rusling
Rochester,
New York
| $2K | +$2.39K | +47 | New |
|
331
Lazard Asset Management
New York
| $2K | +$3K | +59 | New |
|
|
BBHC
332
Brown Brothers Harriman & Co
New York
| $1K | +$866 | +17 | New |
|
AZN Hedge Fund Activity: Q2 2013 in Review
331 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q2 2013, worth a combined $5.84B.
Buyers outnumbered sellers: 331 funds opened new AZN positions and 0 closed out — a net gain of 331 holders — while 0 added to existing stakes and 0 trimmed.
- 331 institutional investors held AstraZeneca (AZN) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $5.84B of AstraZeneca stock for Q2 2013.
- 331 funds opened new AstraZeneca positions in Q2 2013 and 0 closed out, a net change of +331 holders.
Based on aggregated 13F filings for Q2 2013.